Internal-External Percutaneous Transhepatic Biliary Drainage for Patients with Malignant Obstructive Jaundice

  • Xu, Chuan (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Lv, Peng-Hua (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Huang, Xin-En (Department of Chemotherapy, Jiangsu Cancer Hospital, Nanjing Medical University) ;
  • Sun, Ling (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Wang, Shu-Xiang (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Wang, Fu-An (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
  • Published : 2014.11.28


Purpose: To evaluate the effect of internal-external percutaneous transhepatic biliary drainage (IEPTBD) for patients with malignant obstructive jaundice. Methods: During the period of January 2008 and July 2013, internal-external drainage was performed in 42 patients with malignant obstructive jaundice. During the procedure, if the guide wire could pass through the occlusion and into the duodenum, IEPTBD was performed. External drainage biliary catheter was placed if the occlusion was not crossed. Newly onset of infection, degree of bilirubin decrease and the survival time of patients were selected as parameters to evaluate the effect of IEPTBD. Results: Twenty newly onset of infection were recorded after procedure and new infectious rate was 47.6%. Sixteen patients with infection (3 before, 13 after drainage) were uncontrolled after procedure, 12 of them (3 before, 9 after drainage) died within 1 month. The mean TBIL levels declined from 299.53 umol/L before drainage to 257.62 umol/L after drainage, while uninfected group decline from 274.86 umol/L to 132.34 umol/Lp (P < 0.5). The median survival time for uninfected group was 107 days, and for infection group was 43 days (P < 0.05). Conclusions: The IEPTBD drainage may increase the chance of biliary infection, reduce bile drainage efficiency and decrease the long-term prognosis, and the external drainage is a better choice for patients with malignant obstructive jaundice need to biliary drainage.


  1. Ahn S, Lee YS, Lim KS, Lee JL (2013). Malignant biliary obstructions can we predict immediate postprocedural cholangitis after percutaneous biliary drainage? Support Care Cancer, 21, 2321-6.
  2. Boursier J, Cesbron E, Tropet AL, et al (2009). Comparison and improvement of MELD and Child-Pugh score accuracies for the predietion of 6-month mortality in eirrhotic patients. J Clin Gastroenterol, 43, 580-5.
  3. Dambraukas Z, Paskauskas S, Lizdenis P, et al (2003). Percutaneous transhepatic biliary stenting: the first experience and results of the Hospital of Kaunas University of Medicine. Med (Kaunas), 44, 969-76.
  4. De Jong E.A, Moelker A, Leertouwer T, et al (2013). Percutaneous Transhepatic Biliary Drainage in Patients with Postsurgical Bile Leakage and Nondilated Intrahepatic Bile Ducts. Dig Surg, 30, 444-50.
  5. Englesbe MJ, Dawes LG (2005). Resistant pathogen in biliary obstruction: importance of cultures to guide antibiotic therapy. HPB, 7, 144-8.
  6. Jong Kyoung Choi, Ji Kon Kyu, Sang Hyub Lee, et al (2013). Palliative treatment of unresectable hepatocellular carcinoma with obstructive jaundice using biliary drainage with subsequent transarterial chemoembolization. J Palliat Med, 16, 1026-33.
  7. Herzog T, Belyaev O, Hessam S, et al (2012). Bacteribilia with resistant microorganisms after preoperative biliary drainage the influence of bacteria on postoperative outcome. Scand J Gastroenterol, 47, 827-35.
  8. Ho CS, Warkentin AE (2013). Evidence-based decompression in malignant biliary obstruction. Korean J Radiol, 13, S56-61.
  9. Kaya M, Bestas R, Bacalan F, et al (2012). Microbial profile and antibiotic sensitivity pattern in bile cultures from endoscopic retrograde cholangiography patients. World J Gastroenterol, 18, 3585-9.
  10. Lofts FJ, Evans TR, Mansi JL, Glees JP, Knight MJ (1997). Bile duct stents: is there an increased rate of complications in patients receiving chemotherapy? Eur J Cancer, 33, 209-13.
  11. Manwong M, Songserm N, Promthet S et al (2013). Risk factors for cholangiocarcinoma in the lower part of Northeast Thailand: a hospital-based caseocontrol study. Asian Pac J Prev, 14, 5953-6.
  12. Namias N, Demoya M, Sleeman D, et al (2005). Risk of postoperative infection in patients with bactibilia undergoing surgery for obstructive jaundice. Surg Infect, 6, 323-8.
  13. Ozden I, Tekant Y, Bilge O, et al (2005). Endoscopic and radiologic interventions as the leading causes of severe cholangitis in a tertiary referral center. Am J Surg, 189, 702-6.
  14. Simmons DT, Baron TH, Petersen BT, et al (2006). A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma. Am J Gastroenterol, 64, 1792-6.
  15. Todoroki T (2000). Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepatogastroenterology, 47, 644-9.
  16. Westwood DA, Fernando C, Connor Sj, et al (2010). External percutaneous transhepatic billary drainage for malignant biliary obstruction: a retrospective analysis. J Med Imag Rad Oncol, 54, 108-10.
  17. Xu C, Huang XE, Lv PH, et al (2014). Analysis of different ways of drainage for obstructive jaundice caused by hilar cholangiocarcinoma. Asian Pac J Cancer Prev, 15, 5617-20.
  18. Yu Li sol, Chang Won Kim, et al (2010). Early infectious complications of percutaneous metallic stent insertion for malignant biliary obstruction. AJR Am J Roentgenol, 194, 261-5.
  19. Zhu HD, Guo JH, Teng GJ, et al (2012). A novel biliary loaded 125 I seeds in patients with malignant biliary obstruction: Preliminary results versus a conventional biliary stent. J Hepatol, 56, 1104-11.

Cited by

  1. Comparison of Infection between Internal-External and External Percutaneous Transhepatic Biliary Drainage in Treating Patients with Malignant Obstructive Jaundice vol.16, pp.6, 2015,
  2. FDG-PET/CT Manifestation of Tumor Seeding Along Percutaneous Biliary Drainage Catheter Tract vol.40, pp.10, 2015,
  3. Safety and Efficacy of a Mouth-Rinse with Granulocyte Colony Stimulating Factor in Patients with Chemotherapy-Induced Oral Mucositis vol.17, pp.1, 2016,
  4. A Clinical Study on Juheli (Recombinant Human Interleukin - 11) in the Second Prevention of Chemotherapy Induced Thrombocytopenia vol.17, pp.2, 2016,
  5. Regarding “Risk Factors for Immediate and Delayed-Onset Fever After Percutaneous Transhepatic Biliary Drainage” vol.39, pp.5, 2016,